OneChain Immunotherapeutics
Wilmar Castillo Avila is a seasoned professional in the field of biomedicine, currently serving as a Senior Project Manager at OneChain Immunotherapeutics since October 2020. Prior to this role, Wilmar held a similar position at Albajuna Therapeutics from March 2019 to October 2020 and at Spherium Biomed from January 2014 to January 2019, showcasing a strong track record in project management. Earlier career experience includes working as a Senior R&D Scientist at Grupo Ferrer Internacional and as a PhD student at Institut Català d'Oncologia (ICO). Academic credentials include a PhD in Biomedicine and a Master of Science in Biomedicine, both from Universitat de Barcelona, as well as a Bachelor of Science in Biology from the same institution.
This person is not in any teams
OneChain Immunotherapeutics
OneChain Immunotherapeutics is a spin-off Company from Instituto de Investigación contra la Leucemia Josep Carreras and ICREA, that aims to develop CAR-T candidates against different antigens as a treatment for hematological malignancies based on the know-how of Dr. Pablo Menéndez.